Outlook Therapeutics® Adds Global Commercial Expertise with Appointment of Jedd Comiskey as Senior VP – Head of Europe

<p>ISELIN, N.J., Nov. 14, 2023 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve FDA approval for the first ophthalmic formulation of bevacizumab for the treatment of retinal diseases, today announced the appointment of Jedd Comiskey as Senior VP – Head of Europe. Mr. Comiskey has a successful track record […]</p>
<p>The post <a href="https://forextv.com/top-news/outlook-therapeutics-adds-global-commercial-expertise-with-appointment-of-jedd-comiskey-as-senior-vp-head-of-europe/">Outlook Therapeutics® Adds Global Commercial Expertise with Appointment of Jedd Comiskey as Senior VP – Head of Europe</a> appeared first on <a href="https://forextv.com">ForexTV</a>.</p>